Related Experiment Video
Updated: Aug 20, 2026
Using Mouse Oocytes to Assess Human Gene Function During Meiosis I
Published on: April 10, 2018
Oocyte-based screening system for anti-microtubule agents
Deug-Young Shin1, Tae-Saeng Choi
1Department of Microbiology, College of Medicine, Dankook University, Anseo, Chonan, Korea.
Abstract:
Taxol and vinblastine have been widely used in cancer chemotherapy as anti-microtubule agents. However, there are on-going efforts to find new anti-microtubule agents with fewer of the side effects associated with these drugs, such as toxicity or the development of resistance. The standard method used to identify anti-microtubule agents has been the in vitro microtubule polymerization assay. One limitation of this system is that the only compounds selected are those that act on tubulin. Novel compounds whose targets are upstream or are related unknown molecules are not detected. Therefore, many researchers have recently tried to develop novel, phenotype-based drug screening systems. In this study, we developed an oocyte-based screening system for anti-microtubule agents. Dramatic phenotypic changes in microtubules can easily be observed in ovulated oocytes treated with microtubule-stabilizing or -destabilizing agents, such as taxol or vinblastine. After culturing with test samples for 5 h, oocytes were analyzed with fluorescence microscopy after immunostaining. In the oocyte-based screening system, the effective dose (ED50) of taxol for microtubule polymerization is approximately 5 nM, and the ED50 of vinblastine for microtubule depolymerization is approximately 2.5 nM. In addition, taxol-like and vinblastine-like compounds can be evaluated simultaneously in a single assay using this system.
Insights
Researchers developed a novel oocyte-based screening system to identify new anti-microtubule agents for cancer chemotherapy. This method detects compounds with diverse mechanisms, overcoming limitations of traditional assays and enabling simultaneous evaluation of drug candidates.
Area of Science:
- Cell Biology
- Pharmacology
- Drug Discovery
Background:
- Taxol and vinblastine are established anti-microtubule chemotherapy drugs.
- Existing screening methods primarily identify tubulin-targeting agents.
- There is a need for novel anti-microtubule agents with improved side-effect profiles and mechanisms of action.
Purpose of the Study:
- To develop a novel, phenotype-based screening system for anti-microtubule agents.
- To identify compounds that affect microtubule dynamics through diverse mechanisms.
- To create a system capable of evaluating multiple drug candidates simultaneously.
Main Methods:
- Development of an oocyte-based drug screening system.
- Utilizing ovulated oocytes to observe microtubule phenotypic changes.
- Analysis of oocytes via fluorescence microscopy after immunostaining following a 5-hour incubation with test compounds.
Main Results:
- The oocyte system effectively visualizes microtubule stabilization and destabilization.
- The effective dose (ED50) for taxol (microtubule polymerization) was approximately 5 nM.
- The ED50 for vinblastine (microtubule depolymerization) was approximately 2.5 nM.
- The system allows for simultaneous evaluation of taxol-like and vinblastine-like compounds.
Conclusions:
- An oocyte-based screening system offers a sensitive and versatile platform for identifying anti-microtubule agents.
- This phenotype-based approach can detect novel compounds with mechanisms beyond direct tubulin interaction.
- The system facilitates efficient screening and simultaneous assessment of drug candidates, accelerating the discovery of new cancer therapeutics.
